Content about Diabetes mellitus type 2

June 20, 2011
Q&A: A new drug for Type 2 diabetes — Wa'el Hashad, Boehringer Ingelheim

Last month, the Food and Drug Administration approved Tradjenta (linagliptin), an oral Type 2 diabetes drug made by German drug maker Boehringer Ingelheim and Indianapolis-based Eli Lilly. The drug belongs to the class known as dipeptidyl peptidase-4 inhibitors, which also includes Merck’s Januvia (sitagliptin). With diabetes affecting some 26 million Americans and growing rapidly, Drug Store News spoke with Wa’el Hashad, BI’s VP cardiovascular and metabolic disorders marketing, about what the approval of Tradjenta means for the diabetes market.


June 17, 2011
Liraglutide may prompt optimal blood-glucose levels in Type 1 diabetics

A popular Type 2 diabetes treatment may help Type 1 diabetics achieve control of their blood-glucose levels, according to a small, observational study conducted at the University of Buffalo.

May 26, 2011
Court grants Amylin temporary restraining order to bar Lilly from using same sales team

Eli Lilly is temporarily barred from using the same sales team to market two diabetes drugs, under a court order issued Thursday.

May 19, 2011
Avandia to be available only by mail order in November, FDA asserts

A controversial GlaxoSmithKline drug for treating Type 2 diabetes no longer will be available through retail pharmacies as of Nov. 18, the Food and Drug Administration announced Wednesday.

April 25, 2011
Giant Eagle takes HBW to new heights

You can’t be all things to all people, but you can be all things to one person. That’s the opportunity Giant Eagle is grabbing with the number of ways the Pittsburgh food-and-pharmacy retailer interacts with patients. 


“Our goal is to help those within our communities live healthier, longer lives,” Dan Donovan, Giant Eagle spokesman, told Drug Store News. “We look to do this in a number of ways … [through] initiatives, such as our health and beauty care business, in-store retail health clinics and our group of skilled dietitians.”


April 12, 2011
Study: POS electronic safety check can reduce heart attack risk among diabetes patients

A point-of-sale safety check may reduce the risk of patients unsafely receiving a drug for Type 2 diabetes that may increase their risk of heart attack, according to a new study conducted by pharmacy benefit manager Prime Therapeutics and scheduled for presentation at the 23rd annual meeting of the Academy of Managed Care Pharmacy in Minneapolis.

March 25, 2011
Actos cuts Type 2 diabetes risk among majority of patients, study finds

A drug for Type 2 diabetes made by Takeda Pharmaceutical taken in the morning prevented the disease from developing in nearly three-quarters of patients who were at risk, according to a new study in the New England Journal of Medicine.

March 18, 2011
Journal notes heart-related risks posed by Avandia

With respect to the Type 2 diabetes drug Avandia, British drug maker GlaxoSmithKline has another medical study to worry about.

March 15, 2011
Study: Metformin best first-line diabetes treatment

While several drugs to treat Type 2 diabetes are on the market, researchers have found that the best first-line option is metformin.

February 9, 2011
American Diabetes Association teams up with Together Rx Access

The American Diabetes Association is working with an organization that offers free prescription drug savings cards to help increase access to diabetes medications.

February 2, 2011
Decision Resources: Bydureon could promote weight loss among patients

Eli Lilly’s and Amylin Pharmaceuticals’ Type 2 diabetes drug, Bydureon, appears to work better at promoting weight loss than drugs made by Takeda and Merck, but it could face a challenger of its own.

January 27, 2011
Amylin trims losses in Q4, full-year results

Amylin Pharmaceuticals continued to experience losses in sales and profits during fourth quarter 2010 and for the year as a whole, but losses were lower than in 2009, according to financial results released by the drug maker Wednesday.

January 21, 2011
Obesity and its toll are soaring, CDC says

Obesity rates continue to soar among the U.S. population, particularly in children. And the result, the Centers for Disease Control and Prevention reported, leads both to “psychosocial problems and to cardiovascular risk factors, such as hypertension, high cholesterol and abnormal glucose tolerance or diabetes.”

January 18, 2011
Mylan's generic Precose gets green light from FDA

The Food and Drug Administration has approved a generic diabetes drug made by Mylan, the drug maker said Tuesday.

January 7, 2011
Kombiglyze XR now available

A new oral treatment for Type 2 diabetes hit the shelves Friday.

January 5, 2011
Obesity epidemic feeds weight-loss product sales



Sales of diet-aid and weight-loss solutions for the past year have been relatively flat, but a confluence of factors — childhood obesity approaching “epidemic” status combined with the real need to reduce escalating healthcare costs connected to obesity — could become a real driver behind weight-loss products in the coming year. 


December 7, 2010
Reporters Notebook, Chain Pharmacy 12/13/10

Supplier News — Fera Pharmaceuticals has recently launched two new topical ointments. The New York-based company has developed Ilotycin (erythromycin) and Garamycin (gentamicin) ophthalmic ointments, both for the treatment of bacterial infections of the eye. “Our goal is simple: to keep more quality healthcare choices alive for the people who need them,” company co-founder Frank DellaFera said.





December 2, 2010
Decision Resources: Type 2 diabetes market in China to nearly double by 2014

A growing drug-treated population will cause the Type 2 diabetes drug market in China to increase to $2.5 billion by 2014 ...

November 17, 2010
Byetta may cut cardiovascular risk for diabetes patients

A Type 2 diabetes drug marketed by Eli Lilly and Amylin Pharmaceuticals may lower the...

November 8, 2010
Arena, Eisai: Lorcaserin produced weight loss in Type 2 diabetics during trial

Two drug makers conducting a late-stage clinical trial of a drug for treating overweight and...

November 7, 2010
FDA approves Kombiglyze XR

The Food and Drug Administration approved the first and only once-a-day metformin extended-release plus dipeptidyl...

November 7, 2010
Study finds GLP-1 analogues may improve blood-glucose levels, BMI

A new study conducted by University of Toronto researchers found that GLP-1 analogues not only...

October 31, 2010
Stater Bros. to offer free diabetes drugs at select locations

Supermarket chain Stater Bros. will mark National Diabetes Awareness Month by offering free diabetes drugs...

October 27, 2010
Decision Resources: More patients switch to Onglyza from Merck's Type 2 diabetes drugs

Many Type 2 diabetes patients who use the drug Onglyza (saxagliptin) switched to that drug...

October 6, 2010
Spherix's Type 2 diabetes drug caused 'significant drop' in patients' HbA1c levels

Relatively healthy patients with Type 2 diabetes experienced a significant reduction in blood-sugar levels when...

© 2013 Drug Store News. All Rights Reserved.